Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2026International Journal of Clinical OncologyOpen Access

Efficacy of a new surgical indicator for lung cancer with interstitial lung disease based on the gender–age–physiology staging system

View Full Paper
Ask AI
Bookmark
Share

Authors

YIYoshito ImamuraKNKeita NakanishiHHHeng Huang

Discussion

Loading...

Member takes

Overview

Retrospective study shows predicted ILD-GAP stage guides resection strategy in lung cancer with interstitial lung disease, indicating improved five-year survival stratification.

Key Points

  • To evaluate the prognostic value of the predicted ILD Gender–Age–Physiology (GAP) stage—incorporating predicted postoperative lung function—as a surgical indicator for patients with early-stage lung cancer and interstitial lung disease.
  • Retrospectively analyzed 125 patients with clinical stage 1 lung cancer and interstitial lung disease who underwent surgical resection between 2011 and 2023.
  • Compared postoperative outcomes across surgical procedures (anatomical resection vs. wedge resection) stratified by predicted ILD-GAP stage.
  • The 5-year overall survival was significantly higher with anatomical resection than wedge resection in patients with predicted ILD-GAP stage ≤ 2 (75.0% vs. 21.3%, p < 0.001), but showed no difference in stage 3 (27.8% vs. 21.3%, p = 0.934).
  • Multivariate analysis identified anatomical resection with predicted ILD-GAP stage ≤ 2 (p = 0.009), diffusing capacity of carbon monoxide (p = 0.043), and pathological stage 1 (p = 0.035) as independent prognostic factors.
  • The predicted ILD-GAP staging system demonstrated significantly greater prognostic accuracy for 5-year overall survival compared to the standard ILD-GAP stage (AUC: 0.735 vs. 0.653, p = 0.040).

Cite This Study

Imamura et al. (2026) studied this question.

synapsesocial.com/papers/6a8aadc57677a3411444631bhttps://doi.org/10.1007/s10147-026-03164-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer2021 · 17 citations
  2. 2An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management2011 · 7,347 citations